Literature DB >> 17518699

The olive constituent oleuropein exhibits proteasome stimulatory properties in vitro and confers life span extension of human embryonic fibroblasts.

Magda Katsiki1, Niki Chondrogianni, Ioanna Chinou, A Jennifer Rivett, Efstathios S Gonos.   

Abstract

Normal human fibroblasts undergo replicative senescence due to both genetic and environmental factors. Senescence and aging can be further accelerated by exposure of cells to a variety of oxidative agents that contribute among other effects to the accumulation of damaged proteins. The proteasome, a multicatalytic nonlysosomal protease, has impaired function during aging, while its increased expression delays senescence in human fibroblasts. The aim of this study was to identify natural compounds that enhance proteasome activity and exhibit antiaging properties. We demonstrate that oleuropein, the major constituent of Olea europea leaf extract, olive oil and olives, enhances the proteasome activities in vitro stronger than other known chemical activators, possibly through conformational changes of the proteasome. Moreover, continuous treatment of early passage human embryonic fibroblasts with oleuropein decreases the intracellular levels of reactive oxygen species (ROS), reduces the amount of oxidized proteins through increased proteasome-mediated degradation rates and retains proteasome function during replicative senescence. Importantly, oleuropein-treated cultures exhibit a delay in the appearance of senescence morphology and their life span is extended by approximately 15%. In summary, these data demonstrate the beneficial effect of oleuropein on human fibroblasts undergoing replicative senescence and provide new insights towards enhancement of cellular antioxidant mechanisms by natural compounds that can be easily up-taken through normal diet.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17518699     DOI: 10.1089/rej.2006.0513

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  43 in total

1.  Phenolic secoiridoids in extra virgin olive oil impede fibrogenic and oncogenic epithelial-to-mesenchymal transition: extra virgin olive oil as a source of novel antiaging phytochemicals.

Authors:  Alejandro Vazquez-Martin; Salvador Fernández-Arroyo; Sílvia Cufí; Cristina Oliveras-Ferraros; Jesús Lozano-Sánchez; Luciano Vellón; Vicente Micol; Jorge Joven; Antonio Segura-Carretero; Javier A Menendez
Journal:  Rejuvenation Res       Date:  2012-01-09       Impact factor: 4.663

2.  Small Molecule Enhancement of 20S Proteasome Activity Targets Intrinsically Disordered Proteins.

Authors:  Corey L Jones; Evert Njomen; Benita Sjögren; Thomas S Dexheimer; Jetze J Tepe
Journal:  ACS Chem Biol       Date:  2017-08-01       Impact factor: 5.100

3.  Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts.

Authors:  Suzanne Kapeta; Niki Chondrogianni; Efstathios S Gonos
Journal:  J Biol Chem       Date:  2010-01-12       Impact factor: 5.157

Review 4.  Therapeutics role of olive fruits/oil in the prevention of diseases via modulation of anti-oxidant, anti-tumour and genetic activity.

Authors:  Arshad H Rahmani; Aqel S Albutti; Salah M Aly
Journal:  Int J Clin Exp Med       Date:  2014-04-15

Review 5.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.

Authors:  Qian Huang; Maria E Figueiredo-Pereira
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

6.  Effects of Ghrelin on the Proteolytic Pathways of Alzheimer's Disease Neuronal Cells.

Authors:  Valentina Cecarini; Laura Bonfili; Massimiliano Cuccioloni; Jeffrey N Keller; Annadora J Bruce-Keller; Anna Maria Eleuteri
Journal:  Mol Neurobiol       Date:  2015-06-02       Impact factor: 5.590

Review 7.  Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders.

Authors:  Evert Njomen; Jetze J Tepe
Journal:  J Med Chem       Date:  2019-03-14       Impact factor: 7.446

Review 8.  Sulforaphane - role in aging and neurodegeneration.

Authors:  Roberto Santín-Márquez; Adriana Alarcón-Aguilar; Norma Edith López-Diazguerrero; Niki Chondrogianni; Mina Königsberg
Journal:  Geroscience       Date:  2019-04-02       Impact factor: 7.713

9.  Novel sorafenib-based structural analogues: in-vitro anticancer evaluation of t-MTUCB and t-AUCMB.

Authors:  Aaron T Wecksler; Sung Hee Hwang; Hiromi I Wettersten; Jennifer E Gilda; Amy Patton; Leonardo J Leon; Kermit L Carraway; Aldrin V Gomes; Keith Baar; Robert H Weiss; Bruce D Hammock
Journal:  Anticancer Drugs       Date:  2014-04       Impact factor: 2.248

Review 10.  Proteasome regulators: activators and inhibitors.

Authors:  Li Huang; Chin Ho Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.